• Ven. Ago 28th, 2026

Quotidiano online di informazione medico-scientifica

CLL

  • Home
  • NICE recommends new treatment option for people with blood and lymphatic cancers

NICE recommends new treatment option for people with blood and lymphatic cancers

Hundreds of people are set to benefit as NICE recommends acalabrutinib for newly diagnosed mantle cell lymphoma and chronic lymphocytic leukaemia Mantle cell lymphoma MCL is a rare and aggressive…

Statin Use May Improve Survival in Patients with Some Blood Cancers

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of…